Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity
Emma C. Thomson, Laura E. Rosen, James G. Shepherd, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 115

Showing 1-25 of 115 citing articles:

Adaptive immunity to SARS-CoV-2 and COVID-19
Alessandro Sette, Shane Crotty
Cell (2021) Vol. 184, Iss. 4, pp. 861-880
Open Access | Times Cited: 1749
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
Allison J. Greaney, Andrea N. Loes, Katharine H. D. Crawford, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 3, pp. 463-476.e6
Open Access | Times Cited: 1215
Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa
Houriiyah Tegally, Eduan Wilkinson, Marta Giovanetti, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 1178
Neutralizing monoclonal antibodies for treatment of COVID-19
Peter C. Taylor, Andrew C. Adams, Matthew M. Hufford, et al.
Nature reviews. Immunology (2021) Vol. 21, Iss. 6, pp. 382-393
Open Access | Times Cited: 706
Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data
Erik Volz, Swapnil Mishra, Meera Chand, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 649
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England
Nicholas G. Davies, Sam Abbott, Rosanna C. Barnard, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 515
Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7
Bo Meng, Steven A. Kemp, Guido Papa, et al.
Cell Reports (2021) Vol. 35, Iss. 13, pp. 109292-109292
Open Access | Times Cited: 412
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
Xiaoying Shen, Haili Tang, Charlene McDanal, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 4, pp. 529-539.e3
Open Access | Times Cited: 377
Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Emma B. Hodcroft, Moira Zuber, Sarah Nadeau, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 329
Ongoing global and regional adaptive evolution of SARS-CoV-2
Nash D. Rochman, Yuri I. Wolf, Guilhem Faure, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 29
Open Access | Times Cited: 242
Recurrent emergence and transmission of a SARS-CoV-2 spike deletion H69/V70
Steven A. Kemp, Bo Meng, Isabella ATM Ferriera, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 220
Two-step strategy for the identification of SARS-CoV-2 variant of concern 202012/01 and other variants with spike deletion H69–V70, France, August to December 2020
Antonin Bal, Grégory Destras, Alexandre Gaymard, et al.
Eurosurveillance (2021) Vol. 26, Iss. 3
Open Access | Times Cited: 210
A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research
Suzannah J. Rihn, Andres Merits, Siddharth Bakshi, et al.
PLoS Biology (2021) Vol. 19, Iss. 2, pp. e3001091-e3001091
Open Access | Times Cited: 209
Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies
Allison J. Greaney, Andrea N. Loes, Katharine H. D. Crawford, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 199
Prolonged evolution of the human B cell response to SARS-CoV-2 infection
Mrunal Sakharkar, C. Garrett Rappazzo, Wendy Wieland‐Alter, et al.
Science Immunology (2021) Vol. 6, Iss. 56
Open Access | Times Cited: 185
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Zijun Wang, Fabian Schmidt, Yiska Weisblum, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 183
SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies
Dami A. Collier, Anna De Marco, Isabella A. T. M. Ferreira, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 166
Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series
Thao Truong, Alex Ryutov, Utsav Pandey, et al.
EBioMedicine (2021) Vol. 67, pp. 103355-103355
Open Access | Times Cited: 162
Kinetics and correlates of the neutralizing antibody response to SARS-CoV-2 infection in humans
Kanika Vanshylla, Veronica Di Cristanziano, Franziska Kleipass, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 6, pp. 917-929.e4
Open Access | Times Cited: 156
Fast-spreading SARS-CoV-2 variants: challenges to and new design strategies of COVID-19 vaccines
Weilin Zhou, Wei Wang
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 132
Structure-Function Analyses of New SARS-CoV-2 Variants B.1.1.7, B.1.351 and B.1.1.28.1: Clinical, Diagnostic, Therapeutic and Public Health Implications
Jasdeep Singh, Jasmine Samal, Vipul Kumar, et al.
Viruses (2021) Vol. 13, Iss. 3, pp. 439-439
Open Access | Times Cited: 119
Mutations of SARS-CoV-2 spike protein: Implications on immune evasion and vaccine-induced immunity
Hylemariam Mihiretie Mengist, Arnaud John Kombe Kombe, Daniel Mekonnen, et al.
Seminars in Immunology (2021) Vol. 55, pp. 101533-101533
Open Access | Times Cited: 105
SARS-CoV-2 genomics: An Indian perspective on sequencing viral variants
Surabhi Srivastava, Sofia Banu, Priya Singh, et al.
Journal of Biosciences (2021) Vol. 46, Iss. 1
Open Access | Times Cited: 102
The SARS-CoV-2 Y453F mink variant displays a pronounced increase in ACE-2 affinity but does not challenge antibody neutralization
Rafael Bayarri‐Olmos, Anne Rosbjerg, Laust Bruun Johnsen, et al.
Journal of Biological Chemistry (2021) Vol. 296, pp. 100536-100536
Open Access | Times Cited: 101
A single mRNA immunization boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
Leonidas Stamatatos, Julie Czartoski, Yu-Hsin Wan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 98
Page 1 - Next Page

Scroll to top